Recital 155, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

The implication of Merck's version of events is that as new prices were agreed in the autumn 1999 meeting and as no further contacts were undertaken between the participants, the infringement ended with the meeting between Merck and the Commission on 27 September 2000.